Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy

Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

(2016) Se-Il Go et al.   Journal of Cachexia Sarcopenia and Muscle

Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma

(2015) Nobuhiko Nakamura et al.   ANNALS OF HEMATOLOGY

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

(2015) Thomas J. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma

(2015) Megan V. Caram et al.   LEUKEMIA & LYMPHOMA

Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone

(2014) Arun Ganti et al.   BRITISH JOURNAL OF HAEMATOLOGY

Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics

(2013) Carla Prado et al.   Anti-Cancer Agents in Medicinal Chemistry

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy

(2013) Hélène Lanic et al.   LEUKEMIA & LYMPHOMA

Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer

(2012) Pierre Soubeyran et al.   JOURNAL OF CLINICAL ONCOLOGY

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

(2011) Frédéric Peyrade et al.   LANCET ONCOLOGY

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

(2010) A. J. Cruz-Jentoft et al.   AGE AND AGEING

Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey

(2010) Gulistan Bahat et al.   Aging Male

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY